Author/Authors :
Gündeş, Ebubekir Necmettin Erbakan Üniversitesi - Meram Tıp Fakültesi - Genel Cerrahi Ana Bilim Dalı, Türkiye , Çakır, Murat Necmettin Erbakan Üniversitesi - Meram Tıp Fakültesi - Genel Cerrahi Ana Bilim Dalı, Türkiye , Aksoy, Faruk Necmettin Erbakan Üniversitesi Meram - Tıp Fakültesi - Genel Cerrahi Anabilim Dalı, Türkiye , Küçükkartallar, Tevfik Necmettin Erbakan Üniversitesi Meram - Tıp Fakültesi - Genel Cerrahi Anabilim Dalı, Türkiye , Taşcı, H. İbrahim Necmettin Erbakan Üniversitesi - Meram Tıp Fakültesi - Genel Cerrahi Ana Bilim Dalı, Türkiye
Abstract :
Objective: The aim of this study was to describe experiences with concurrent parathyroid adenoma and papillary thyroid carcinoma. Methods: Eight patients with concurrent parathyroid adenoma and papillary thyroid carcinoma were identified between 2005 and 2012, and their medical records were reviewed retrospectively. Results: Of the eight patients identified, two were male and six were female; their mean age was 53.6 years. The mean serum calcium concentration was 11.7 mg/dL. Intact parathyroid hormone (iPTH) concentrations were high in all patients, with a mean concentration of 338 pg/ mL. The most frequently used surgical technique was total thyroidectomy plus parathyroid adenoma excision (n=6). The mean size of the thyroid carcinoma was 1.2 cm, and one case showed metastatic lymph nodes in the central compartment. The mean parathyroid adenoma size was found to be 2.1(0.6- 3.5) cm, according to the longest size of the adenom. Six patients (75%) developed postoperative complications, including temporary symptomatic hypocalcemia in 4 patients (50%), hematoma development in 1 patient (12.5%) and temporary vocal cord paralysis in one patient (12.5%). Conclusion: Thyroid carcinoma and parathyroid adenoma are rarely concomitant. Rarely hyperparathyroidism may be accompanied with thyroid carcinomas so preoperatively thyroid gland should be properly examined. Thyroid with parathyroid surgery are risk factors of recurrent laryngeal nerve injury and hypoparathyroidism.